Health Canada announced that serious adverse reports related to abnormal heart rhythms have been received domestically related to Remogen, which contains ibogaine.
Under this advisory, the government has recently seized unauthorized products from Phytostan Enterprise Inc. containing the previously mentioned ingredient.
MORE INDUSTRY NEWS
- Organic whole milk kefir introduced by Wallaby Yogurt Company
- Green Beaver releases new toothpaste
- Quarterly revenue growth for GreenSpace Brands Inc. at 185 per cent
Phytostan Enterprise Inc. is a Quebec-based distributor was selling products containing ibogaine under the names Remogen, Ibo+Plus, Endabuse and Iboga.
Health Canada has now partnered with Canada Border Services Agency to help prevent any future imports of products containing ibogaine.
There have also been international reports of serious adverse reactions associated with products containing ibogaine, including death, respiratory arrest, cardiac problems such as irregular heartbeat, seizures, and symptoms related to psychiatric and metabolic dysfunction.
Consumers are encouraged to report any adverse reactions associated with the use of these products to HealthCanada. Canadians are also encouraged to report complaints about health products to Health Canada by calling toll-free to 1-800-267-9675, or complete an online complaint form.
